Abstract
The increasing bacterial resistance to antibiotics is a global concern that urges the development of new drugs to treat serious infections. Tuberculosis is caused by the bacteria Mycobacterium tuberculosis. One of the reasons for the high mortality number caused by tuberculosis is the emergence of many new bacterial stains that are multiresistant to first line commercial drugs. One strate…